Search results
Wave of Amicus Briefs Back Drug Price Plan at Trial Court Stage
Bloomberg Law· 5 days agoThe Biden administration’s efforts to fend off legal challenges from the pharmaceutical industry battling Medicare drug price negotiations has drawn reinforcements from officials and academics defending the program.
Unveiling Cigna (CI) Q1 Outlook: Wall Street Estimates for Key Metrics
Zacks· 2 days agoFree Report) is predicted by Wall Street analysts to post quarterly earnings of $6.17 per share, reflecting an increase of 14.1% compared to the same period last year. Analysts expect 'Medical Care Ratio - Cigna Healthcare' to come in at 81.9%.